Suppliers in Woonsocket, RI
9 Medicare Suppliers found. Showing 1 - 9
 Cvs Pharmacy #00590 Durable Medical Equipment & Medical Supplies Location: 1054 Cass Ave, Woonsocket, Rhode Island 02895 Phone: (401) 767-3600 |
Cvs Pharmacy #02474 Durable Medical Equipment & Medical Supplies Location: 450 Clinton St, Woonsocket, Rhode Island 02895 Phone: (401) 767-2120 |
Walgreens Pharmacy 03898 Durable Medical Equipment & Medical Supplies Location: 45 Cumberland St, Woonsocket, Rhode Island 02895 Phone: (401) 765-5010 |
James J Cloutier Dpm Facfas Cws Medicare Supplier Location: 919 Diamond Hill Rd, Woonsocket, Rhode Island 02895 Phone: (401) 766-4444 |
Osucc Woonsocket Medicare Supplier Location: 25 John A Cummings Way, Woonsocket, Rhode Island 02895 Phone: (401) 235-7310 |
South County Artificial Limb Co., I Prosthetic/Orthotic Supplier Location: 265 Mendon Rd, Woonsocket, Rhode Island 02895 Phone: (401) 769-1314 |
Woonsocket Medicare Supplier Location: 166 Cass Ave, Woonsocket, Rhode Island 02895 Phone: (401) 769-2511 |
Atlantic Family Eye Care Inc Medicare Supplier Location: 2345 Mendon Rd, Woonsocket, Rhode Island 02895 Phone: (401) 765-5430 |
Vision Associates Inc. Medicare Supplier Location: 148 Social St, Woonsocket, Rhode Island 02895 Phone: (401) 769-2755 |
News Archive
Obama discretely lobbying for public option in Senate health bill
"Despite months of outward ambivalence about creating a government health insurance plan, the Obama White House has launched a behind-the-scenes campaign to get divided Senate Democrats to take up some version of the idea for a final vote in the coming weeks," The Los Angeles Times reports.
Research finds evidence linking number of ribosomal genes to bacterial growth rate and efficiency
Microbes that can reproduce rapidly in times of plenty have an evolutionary stockpile of extra genes that allows them to quickly respond to changing conditions such as oil spills or outbreaks of intestinal diseases.
Keryx Biopharmaceuticals initiates Phase 3 registration clinical trial for perifosine
Æterna Zentaris Inc., a global biopharmaceutical company focused on oncology and endocrine therapy, today announced the initiation, by its partner Keryx Biopharmaceuticals Inc., of a Phase 3 registration clinical trial for perifosine (KRX-0401), the Company's PI3K/Akt pathway inhibitor, in relapsed/refractory multiple myeloma patients.
FDA gives new safety information on proper use of Tussionex as a cough suppressant
The U.S. Food and Drug Administration issued an alert today on the safe and correct use of Tussionex Pennkinetic Extended-Release Suspension in response to numerous reports of adverse events - including death - associated with the misuse and inappropriate use of this potent cough medication.
› Verified 3 days ago